BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16409423)

  • 21. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
    Park W; Hicks DM; Khandwala F; Richter JE; Abelson TI; Milstein C; Vaezi MF
    Laryngoscope; 2005 Jul; 115(7):1230-8. PubMed ID: 15995512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of baseline symptom severity on patient-reported outcomes in gastroesophageal reflux disease.
    Junghard O; Wiklund IK
    Eur J Gastroenterol Hepatol; 2007 Jul; 19(7):555-60. PubMed ID: 17556901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term treatment of patients with symptomatic gastroesophageal reflux disease comparing costs and efficacy over 6 months of treatment with Nexium On-Demand Treatment or Nexium continuous treatment. An open, randomised multi-center study].
    Beglinger C; Thalmann C; Szucs T; Michetti P
    Praxis (Bern 1994); 2006 Mar; 95(13):483-7. PubMed ID: 16602668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
    Janiak P; Thumshirn M; Menne D; Fox M; Halim S; Fried M; Brühlmann P; Distler O; Schwizer W
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1259-65. PubMed ID: 17944740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trial: intragastric acid control in patients who have Barrett's oesophagus--comparison of once- and twice-daily regimens of esomeprazole and lansoprazole.
    Spechler SJ; Barker PN; Silberg DG
    Aliment Pharmacol Ther; 2009 Jul; 30(2):138-45. PubMed ID: 19438416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study.
    Rush DR; Stelmach WJ; Young TL; Kirchdoerfer LJ; Scott-Lennox J; Holverson HE; Sabesin SM; Nicholas TA
    J Fam Pract; 1995 Aug; 41(2):126-36. PubMed ID: 7636452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response?
    Talley NJ; Vakil N; Lauritsen K; van Zanten SV; Flook N; Bolling-Sternevald E; Persson T; Björck E; Lind T;
    Aliment Pharmacol Ther; 2007 Sep; 26(5):673-82. PubMed ID: 17697201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system.
    Vasiliadis KV; Viazis N; Vlachogiannakos J; Sgouros SN; Stefanidis G; Archimandritis A; Karamanolis DG
    Am J Gastroenterol; 2010 Feb; 105(2):308-13. PubMed ID: 19809412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Participation in a clinical trial influences the future management of patients with gastro-oesophageal reflux disease in general practice.
    Meineche-Schmidt V; Hvenegaard A; Juhl HH
    Aliment Pharmacol Ther; 2006 Oct; 24(7):1117-25. PubMed ID: 16984506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management strategy for patients with gastroesophageal reflux disease: a comparison between empirical treatment with esomeprazole and endoscopy-oriented treatment.
    Giannini EG; Zentilin P; Dulbecco P; Vigneri S; Scarlata P; Savarino V
    Am J Gastroenterol; 2008 Feb; 103(2):267-75. PubMed ID: 18289194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
    Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
    J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux.
    Reichel O; Dressel H; Wiederänders K; Issing WJ
    Otolaryngol Head Neck Surg; 2008 Sep; 139(3):414-20. PubMed ID: 18722223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rapidity of pain relief, medication requirement and patient satisfaction with reflux treatment in the physician's office].
    Dohmen W; Fuchs W
    MMW Fortschr Med; 2005 Apr; 147 Suppl 1():21-5. PubMed ID: 16739368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of dose and timing of esomeprazole administration on 24-h, daytime and night-time acid inhibition in healthy volunteers.
    Wilder-Smith C; Röhss K; Bokelund Singh S; Sagar M; Nagy P
    Aliment Pharmacol Ther; 2010 Nov; 32(10):1249-56. PubMed ID: 20955444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic cough and esomeprazole: a double-blind placebo-controlled parallel study.
    Faruqi S; Molyneux ID; Fathi H; Wright C; Thompson R; Morice AH
    Respirology; 2011 Oct; 16(7):1150-6. PubMed ID: 21707852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Esomeprazole, a new proton pump inhibitor: pharmacological characteristics and clinical efficacy.
    Thitiphuree S; Talley NJ
    Int J Clin Pract; 2000 Oct; 54(8):537-41. PubMed ID: 11198734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors.
    Hawkey C; Talley NJ; Yeomans ND; Jones R; Sung JJ; Långström G; Naesdal J; Scheiman JM;
    Am J Gastroenterol; 2005 May; 100(5):1028-36. PubMed ID: 15842575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical trial: healing of NSAID-associated gastric ulcers in patients continuing NSAID therapy - a randomized study comparing ranitidine with esomeprazole.
    Goldstein JL; Johanson JF; Hawkey CJ; Suchower LJ; Brown KA
    Aliment Pharmacol Ther; 2007 Oct; 26(8):1101-11. PubMed ID: 17894652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of chronic posterior laryngitis with esomeprazole.
    Vaezi MF; Richter JE; Stasney CR; Spiegel JR; Iannuzzi RA; Crawley JA; Hwang C; Sostek MB; Shaker R
    Laryngoscope; 2006 Feb; 116(2):254-60. PubMed ID: 16467715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.